Nuvalent Inc - Ordinary Shares - Class A

-1.24 (-4.10%)
5:13:47 PM EDT: $29.01 0.00 (0.00%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Nuvalent Inc - Ordinary Shares - Class A Stock, NASDAQ:NUVL

One Broadway, 14th floor, Cambridge, Massachusetts 02142
United States of America
Phone: +1.857.357.7000
Number of Employees: 40


Nuvalent, Inc. operates as a preclinical stage biopharmaceutical company. The company creates precisely targeted therapies for patients with cancer designed to overcome the limitations of existing therapies for clinically proven kinase targets. Its focus its discovery efforts on small molecule inhibitors of kinases, a class of cellular targets that can play a central role in cancer growth and proliferation. The company was founded in January 2017 and is headquartered Cambridge, MA.